These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17032574)

  • 1. Contingency management interventions for HIV-related behaviors.
    Haug NA; Sorensen JL
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):154-9. PubMed ID: 17032574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment.
    Mitchell SG; Monico LB; Stitzer M; Matheson T; Sorensen JL; Feaster DJ; Schwartz RP; Metsch L
    J Subst Abuse Treat; 2018 Nov; 94():18-23. PubMed ID: 30243412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contingency management for treatment of substance abuse.
    Stitzer M; Petry N
    Annu Rev Clin Psychol; 2006; 2():411-34. PubMed ID: 17716077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counselor Attitudes Toward Contingency Management for Substance Use Disorder: Effectiveness, Acceptability, and Endorsement of Incentives for Treatment Attendance and Abstinence.
    Aletraris L; Shelton JS; Roman PM
    J Subst Abuse Treat; 2015 Oct; 57():41-8. PubMed ID: 26001821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review.
    Herrmann ES; Matusiewicz AK; Stitzer ML; Higgins ST; Sigmon SC; Heil SH
    J Subst Abuse Treat; 2017 Jan; 72():117-125. PubMed ID: 27394070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive guide to the application of contingency management procedures in clinical settings.
    Petry NM
    Drug Alcohol Depend; 2000 Feb; 58(1-2):9-25. PubMed ID: 10669051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinician-delivered contingency management increases engagement and attendance in drug and alcohol treatment.
    Fitzsimons H; Tuten M; Borsuk C; Lookatch S; Hanks L
    Drug Alcohol Depend; 2015 Jul; 152():62-7. PubMed ID: 25982007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Ultra-Low Magnitude Reinforcers: Findings From a "Real-World" Application of Contingency Management.
    Kropp F; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 Jan; 72():111-116. PubMed ID: 27422452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A perfect platform: combining contingency management with medications for drug abuse.
    Carroll KM; Rounsaville BJ
    Am J Drug Alcohol Abuse; 2007; 33(3):343-65. PubMed ID: 17613963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral therapies for drug abuse.
    Carroll KM; Onken LS
    Am J Psychiatry; 2005 Aug; 162(8):1452-60. PubMed ID: 16055766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Evaluation of a Contingency Management Intervention Addressing Adolescent Substance Use and Sexual Risk Behaviors: Risk Reduction Therapy for Adolescents.
    Letourneau EJ; McCart MR; Sheidow AJ; Mauro PM
    J Subst Abuse Treat; 2017 Jan; 72():56-65. PubMed ID: 27629581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Multi-Target Contingency Management Intervention for HIV Positive Substance Users.
    Stitzer M; Calsyn D; Matheson T; Sorensen J; Gooden L; Metsch L
    J Subst Abuse Treat; 2017 Jan; 72():66-71. PubMed ID: 27624618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive impairment and HIV risk factors: a reciprocal relationship.
    Anand P; Springer SA; Copenhaver MM; Altice FL
    AIDS Behav; 2010 Dec; 14(6):1213-26. PubMed ID: 20232242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivation and Contingency Management Treatments for Substance Use Disorders.
    Walter KN; Petry NM
    Curr Top Behav Neurosci; 2016; 27():569-81. PubMed ID: 25762429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contingency management in group treatment: a demonstration project in an HIV drop-in center.
    Petry NM; Martin B; Finocche C
    J Subst Abuse Treat; 2001 Sep; 21(2):89-96. PubMed ID: 11551737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment.
    Copenhaver M; Avants SK; Warburton LA; Margolin A
    J Psychoactive Drugs; 2003; 35(2):209-18. PubMed ID: 12924743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contingency management interventions: from research to practice.
    Petry NM; Petrakis I; Trevisan L; Wiredu G; Boutros NN; Martin B; Kosten TR
    Am J Psychiatry; 2001 May; 158(5):694-702. PubMed ID: 11329388
    [No Abstract]   [Full Text] [Related]  

  • 20. A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV.
    Moore BA; Rosen MI; Wang Y; Shen J; Ablondi K; Sullivan A; Guerrero M; Siqueiros L; Daar ES; Liu H
    AIDS Behav; 2015 Jun; 19 Suppl 2(0 2):156-62. PubMed ID: 25645326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.